GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                               
                            
                                
                                                                Synonyms: GS-5885 | GS5885 | Harvoni® (ledipasvir + sofosbuvir)
                                 
                                                         
                            
                            
                            
                                 
                                
                                ledipasvir is an approved drug (EMA & FDA (2014)) 
                                                        
                                                    
                                Compound class: 
                                                            Synthetic organic
                                 
                                
                                    
                                        Comment: Ledipasvir is an orally available, direct-acting inhibitor of the hepatitis C virus (HCV) non-structural protein 5A (NS5A) replication complex [1].
                                    
                                 
                            
                            
                          
                                
                                    
                                
                          
                                   
                                   
                                  
                                      
                                     
                                   
                                   
                                    
                                    
                                     | 
                                    
                                        
                                         
  | 
                                    
                                
                                |||||||||||||||||||||||||||||||||||
Classification ![]()  | 
                                                    |
| Compound class | Synthetic organic | 
| Approved drug? | Yes. EU EMA (2014) | US FDA (2014) | 
| WHO Essential Medicine | WHO Essential Medicines List (EML) (23rd List, 2023). Access PDF version. Click to view more information about the WHO Model Lists of Essential Medicines.  | 
                                                        
International Nonproprietary Names ![]()  | 
                                                        |
| INN number | INN | 
| 9796 | ledipasvir | 
Synonyms ![]()  | 
                                                        
| GS-5885 | GS5885 | Harvoni® (ledipasvir + sofosbuvir) | 
Database Links ![]()  | 
                                                        |
| CAS Registry No. | 1256388-51-8 (source: WHO INN record) | 
| ChEMBL Ligand | CHEMBL2374220 | 
| DrugBank Ligand | DB09027 | 
| DrugCentral Ligand | 4899 | 
| GtoPdb PubChem SID | 434321706 | 
| PubChem CID | 67505836 | 
| Search Google for chemical match using the InChIKey | VRTWBAAJJOHBQU-KMWAZVGDSA-N | 
| Search Google for chemicals with the same backbone | VRTWBAAJJOHBQU | 
| Search PubMed clinical trials | ledipasvir | 
| Search PubMed titles | ledipasvir | 
| Search PubMed titles/abstracts | ledipasvir | 
| UniChem Compound Search for chemical match using the InChIKey | VRTWBAAJJOHBQU-KMWAZVGDSA-N | 
| UniChem Connectivity Search for chemical match using the InChIKey | VRTWBAAJJOHBQU-KMWAZVGDSA-N | 
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖| 
                                                                     
                                                                         
                                                                         
                                                                             
                                                                         
                                                                         
                                                                           
                                                                           Ledipasvir (links to external site) 
                                                                    
                                                                Cat. No. HY-15602  |